US COVID-19 vaccine green lighted for second stage of human testing

Early data from Moderna Inc's COVID-19 vaccine, the first to be tested in the United States, showed that it produced protective antibodies in a small group of healthy volunteers, the company said on Monday. The data are from eight people who took part in a safety trial that kicked off in March as the global pandemic caused by the novel coronavirus was spreading. In the trial of 45 volunteers, conducted by the...